DHC DIVERSIFIED HEALTHCARE TRUST
Real Estate Investment Trusts · Nasdaq · SEC CIK 1075415 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $367.67M | $365.39M | $366.47M | $379.57M | $388.71M | $382.71M | $386.86M | $379.62M |
| SG&A expense | $14.64M | $19.33M | $14.04M | $12.54M | $12.79M | $11.18M | $9.00M | -$1.25M |
| Interest expense | $37.16M | $37.08M | $37.05M | $46.85M | $48.89M | $50.93M | $57.83M | $59.52M |
| Pretax income | -$52.21M | -$37.97M | -$42.75M | -$47.81M | -$168.79M | -$93.88M | -$10.42M | -$98.96M |
| Income tax | $724,000 | $1.30M | $622,000 | $514,000 | $337,000 | $843,000 | $49,000 | -$38,000 |
| Net income | -$50.23M | -$37.42M | -$43.27M | -$21.22M | -$164.04M | -$91.64M | -$8.99M | -$87.45M |
| EPS (basic) | -0.21 | -0.16 | -0.18 | — | -0.68 | -0.38 | -0.04 | — |
| EPS (diluted) | -0.21 | -0.16 | -0.18 | — | -0.68 | -0.38 | -0.04 | — |
| Dividends declared per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted avg. shares (diluted) | 240.98M | 240.75M | 240.69M | — | 240.38M | 240.13M | 239.96M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $110.66M | $116.79M | $121.77M | $105.41M | $201.37M | $141.77M | $302.58M | $149.85M |
| Intangibles | $17.56M | $18.46M | $19.56M | $20.66M | $21.78M | $23.13M | $24.31M | $26.30M |
| Total assets | $4.19B | $4.24B | $4.27B | $4.36B | $4.68B | $4.76B | $5.00B | $5.14B |
| Long-term debt | $2.44B | $2.44B | $2.44B | $2.44B | — | — | — | $3.05B |
| Total debt | $2.44B | $2.44B | $2.44B | $2.44B | — | — | — | $3.05B |
| Total liabilities | $2.66B | $2.66B | $2.65B | $2.70B | $3.00B | $2.90B | $3.05B | $3.18B |
| Shareholders' equity | $1.53B | $1.58B | $1.62B | $1.67B | $1.69B | $1.85B | $1.95B | $1.96B |
| Net debt | $2.33B | $2.33B | $2.32B | $2.34B | — | — | — | $2.90B |
| Shares outstanding | 242.56M | 242.19M | 242.11M | 242.12M | 242.15M | 241.42M | 241.27M | 241.27M |
| Cash flow statement | ||||||||
| Operating cash flow | $27.39M | $38.38M | $8.34M | -$20.11M | -$49.28M | $53.02M | -$3.24M | $18.20M |
| Capital expenditure | $26.87M | $24.18M | $35.17M | $32.43M | $40.56M | $34.18M | $39.65M | $66.74M |
| Free cash flow | $521,000 | $14.20M | -$26.82M | -$52.54M | -$89.84M | $18.84M | -$42.89M | -$48.54M |
| Investing cash flow | -$26.87M | -$38.75M | $13.58M | $207.42M | $6.12M | -$21.05M | $291.09M | -$66.14M |
| Financing cash flow | -$5.77M | -$3.29M | -$3.87M | -$275.13M | $104.21M | -$190.04M | -$131.05M | -$63.60M |
| Depreciation & amortization | $62.86M | $62.54M | $62.91M | $62.01M | $65.32M | $66.27M | $68.33M | $77.51M |
| Dividends paid | $2.42M | $2.42M | $2.42M | $2.42M | $2.41M | $2.41M | $2.41M | $2.41M |
| Share buybacks | $2.56M | $50,000 | $88,000 | $82,000 | $954,000 | $103,000 | $6,000 | $2,000 |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.